This is a preview of subscription content, log in via an institution to check access.
Reference
Eranki V, et al. Abstract #1134833: Graves disease due to immune reconstitution on Alemtuzumab therapy. Endocrine Practice 28 (Suppl.): S126 abstr. 1134833, No. 5, May 2022. Available from: URL: http://doi.org/10.1016/j.eprac.2022.03.295 [abstract]
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1908, 28 (2022). https://doi.org/10.1007/s40278-022-15756-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-15756-5